#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodegenerative disorder Cushing's syndrome Cystic fibrosis Hereditary hypophosphataemic rickets Nasopharyngeal cancer Usher's syndrome Glomerulonephritis membranoproliferative Acute graft versus host disease in liver Hormone-dependent prostate cancer Neonatal alloimmune thrombocytopenia Progressive supranuclear palsy Ventricular tachycardia Insulinoma Acute hepatic failure Graft versus host disease More trials…

    Learn about Rare Diseases

    Isodicentric chromosome 15 syndrome Glycogen storage disease type V – Basic Information Alagille syndrome – Trials in Disease Mantle cell lymphoma – Diagnostics Marginal zone lymphoma – Diagnostics Chondrosarcoma – Life with Disease Chronic granulomatous disease – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Basic Information Synovial sarcoma metastatic – Trials in Disease Systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Interleukin-1 DESMOPRESSIN ACETATE Histamine Hydrochloride Apocynin TTX-381 Dacomitinib Fenfluramine Hydrochloride GRAPHITE Sapropterin Dihydrochloride Timothy Grass Pollen Extract ADCE-D01 AGANIRSEN Tegoprubart Rebisufligene Etisparvovec Transpocart19 F1245/05 Calcium Carbonate Magnesium Sulfate Heptahydrate Nebivolol Ciprofloxacin More therapies…

    Learn about Your Condition

    Septic shock Glanzmann's disease Synovitis Malignant melanoma of eyelid Endocarditis bacterial Bronchiectasis High-grade B-cell lymphoma KBG syndrome Lichen planus Vesicoureteric reflux Tumour thrombosis Milk allergy Oesophagectomy Ear discomfort Hepatic fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Alcohol use disorder

  • Study on Cannabidiol as an Add-On Treatment for Patients with Severe Alcohol Use Disorder During Inpatient Alcohol Cessation

    Recruiting

    2 1
    Investigated Diseases:
    • Alcohol use disorder
    Investigated Drugs:
    • Cannabidiol
    France

  • A Study of Brenipatide Compared to Placebo in Adults with Moderate-to-Severe Alcohol Use Disorder

    Not recruiting

    3 1
    Investigated Drugs:
    • LY3537031
    Belgium Germany

  • Study on Oxytocin for Improving Behavior in Young Adults with Alcohol Use Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    Investigated Drugs:
    • Oxytocin
    Sweden

  • Study on the Effects of Sunobinop on Reducing Alcohol Consumption in Patients with Moderate to Severe Alcohol Use Disorder Seeking Treatment

    Not recruiting

    2 1
    Investigated Diseases:
    • Alcohol use disorder
    Romania

  • Study on Psilocybin for Patients with Alcohol Use Disorder and Depression Symptoms

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    Investigated Drugs:
    • Psilocybine
    France

  • Study on Semaglutide’s Effect on Reducing Alcohol Intake in Patients with Alcohol Use Disorder and Obesity

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    Investigated Drugs:
    • Saline
    • Semaglutide
    Denmark
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!